| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/24/2003 | WO2003033029A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 04/24/2003 | WO2003033015A1 USE OF gp130 ACTIVATORS IN DIABETIC NEUROPATHY |
| 04/24/2003 | WO2003032920A2 Oligonucleotide modulation of cell adhesion |
| 04/24/2003 | WO2003032913A2 Methods and compositions for targeting proteins across the blood brain barrier |
| 04/24/2003 | WO2003032809A2 Modulation of akt-dependent response to prevent restenosis |
| 04/24/2003 | WO2003032727A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 04/24/2003 | WO2003011887A3 Antisense modulation of apolipoprotein b expression |
| 04/24/2003 | WO2003005964A3 Recombinant vsv for the treatment of tumor cells |
| 04/24/2003 | WO2002095016A3 Champ - a cardiac helicase-like factor |
| 04/24/2003 | WO2002088180A3 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds |
| 04/24/2003 | WO2002087614A3 Multivalent vaccine comprising an hiv antigen and an hsv antigen and/or an hpv antigen |
| 04/24/2003 | WO2002072822A3 Als2 gene and amyotrophic lateral sclerosis type 2 |
| 04/24/2003 | WO2002066626A3 Regulation of human mut/nudix nucleoside triphosphate pyrophosphohydrolase |
| 04/24/2003 | WO2002066490A3 Cationic sterol derivatives, ph-sensitive liposomes comprising cationic sterol derivatives and method for loading liposomes with active substances |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002063000A9 Purified and isolated platelet calcium channel nucleic acids and polypeptides and therapeutic and screening methods using same |
| 04/24/2003 | WO2002048344A3 Gene therapy for prostate cancer: sensibilization of cells to dn a damaging drugs and radiation |
| 04/24/2003 | WO2002045431A3 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 04/24/2003 | WO2002043741A3 Methylenetetrahydrofolate reductase inhibitors and use thereof |
| 04/24/2003 | WO2002038171A3 METHODS FOR TREATING DISEASES CAUSED BY DEFICIENCIES OF α-L-IDURONIDASE |
| 04/24/2003 | WO2002031498A3 Protecting therapeutic compositions from host-mediated inactivation |
| 04/24/2003 | WO2002018585A8 Packaging of positive-strand rna virus replicon particles |
| 04/24/2003 | WO2002014527A3 Gp64-null baculoviruses pseudotyped with heterologous envelope proteins |
| 04/24/2003 | WO2002004513A3 Down syndrome critical region 1-like 1 proteins |
| 04/24/2003 | WO2001080900A3 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane |
| 04/24/2003 | WO2001077389A3 Genes expressed in foam cell differentiation |
| 04/24/2003 | WO2001075440A3 Schizophrenia related genes |
| 04/24/2003 | WO2001062791A9 Control of tgf (beta) signaling by km23 superfamily members |
| 04/24/2003 | US20030079242 Animal model for use as tool in diagnosing and treating tumors |
| 04/24/2003 | US20030078410 Expression vector for use in the transfer of genes and preparation of vaccines |
| 04/24/2003 | US20030078406 Methods and compositions for DRM, a secreted protein with cell growth inhibiting activity |
| 04/24/2003 | US20030078405 47 human secreted proteins |
| 04/24/2003 | US20030078391 Nucleotide sequences coding polypeptide for use in treatment of periodontal disease |
| 04/24/2003 | US20030078389 Gamma-heregulin |
| 04/24/2003 | US20030078386 Antibody for use in the treatment of viral, gastrointestinal, autoimmune and cell proiferative disorders |
| 04/24/2003 | US20030078376 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins) |
| 04/24/2003 | US20030078373 Chaperone fragments |
| 04/24/2003 | US20030078370 Antibodies to cyclin E2 protein |
| 04/24/2003 | US20030078230 Stabilizing, shaping to form particles and determining a turbidity parameter of a solution of compacted nucleic acid; drug delivery of DNA to cells, transfection |
| 04/24/2003 | US20030078229 Lyophilizable and enhanced compacted nucleic acids |
| 04/24/2003 | US20030078226 Delivery of polypeptides by secretory gland expression |
| 04/24/2003 | US20030078225 Liposomes |
| 04/24/2003 | US20030078224 An isolated polynucleotide for treating prostate and non-prostate tumors in a gene therapy |
| 04/24/2003 | US20030078222 Human receptor tyrosine kinase |
| 04/24/2003 | US20030078221 Method for treating a Complement System-mediated disease comprising administering a pharmaceutically effective amount of a Nucleic Acid Ligand of a Complement System Protein; SELEX method |
| 04/24/2003 | US20030077827 Transfection of preferential cells; obtain immbolized nucleotide sequences, incubate with cells, recover transfected cells |
| 04/24/2003 | US20030077812 Lentiviral vectors encoding clotting factors for gene therapy |
| 04/24/2003 | US20030077810 CHAMP - a novel cardiac helicase-like factor |
| 04/24/2003 | US20030077808 Nucleotide sequences coding polypeptide for use in the diagnosis of cancer |
| 04/24/2003 | US20030077806 Composition for use in the treatment of lysosomal storage defects |
| 04/24/2003 | US20030077798 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's, diabetes and inflammation |
| 04/24/2003 | US20030077774 Novel polypeptides and nucleic acids encoding same |
| 04/24/2003 | US20030077754 Nucleotide sequences for use in the generation of preferential messenger ribonucleic acids |
| 04/24/2003 | US20030077749 Ucp5 |
| 04/24/2003 | US20030077735 Novel human Kchannel and therapeutic applications thereof |
| 04/24/2003 | US20030077708 Antigen presenting system and methods for activation of T-cells |
| 04/24/2003 | US20030077703 Nucleic acids, proteins, and antibodies |
| 04/24/2003 | US20030077695 Keratinocyte growth factor-2 |
| 04/24/2003 | US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 04/24/2003 | US20030077624 Diagnosing cancer in mammals; obtain sample cells, monitor expression of collapsin protein, amplified concentration of collapsin indicates cancer |
| 04/24/2003 | US20030077614 Nucleic acids for inhibiting hairless protein expression and methods of use thereof |
| 04/24/2003 | US20030077602 Nucleic acids, proteins, and antibodies |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077568 Screening drugs; obtain cell with preferential phenotypic profile, incubate with drug, monitor effect on cells |
| 04/24/2003 | US20030077565 Preservation of corneal graft in vitro; obtain graft, incubate with antisense oligonucleotides in solution, monitor viability of graft tissue |
| 04/24/2003 | US20030077318 Activation lymphocytes; therapy for aids, cancer; immobilization on solid support |
| 04/24/2003 | US20030077280 Monoclonal antibody which specifically recognizes and forms complex with protein located on surface of activated T cells and thereby inhibits T cell activation of B cells |
| 04/24/2003 | US20030077279 Methods for treating vascular disease by inhibiting toll-like receptor-4 |
| 04/24/2003 | US20030077268 Recombinant bacterial cells for delivery of PNP to tumor cells |
| 04/24/2003 | US20030077260 Hybrid matrix implants and explants |
| 04/24/2003 | US20030077258 Comprising one or more chondroitin sulfate proteoglycan (CSPG)-degrading enzymes that promote axonal penetration into damaged nerve tissue and nerve graft |
| 04/24/2003 | US20030077253 Implantable or insertable therapeutic agent delivery device |
| 04/24/2003 | US20030077250 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene |
| 04/24/2003 | US20030077249 DNA coding for one or more recombinant chimeric receptors comprising two or more different cytoplasmic signalling polypeptides; drug delivery system for treating cancer |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | CA2775218A1 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 04/24/2003 | CA2466889A1 Use of the adenoviral e2 late promoter |
| 04/24/2003 | CA2463996A1 Replication competent dual-ad vectors for vaccine and immunotherapy applications |
| 04/24/2003 | CA2463816A1 Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy |
| 04/24/2003 | CA2463641A1 Antisense antiviral agent and method for treating ssrna viral infection |
| 04/24/2003 | CA2463473A1 Targeted therapeutic proteins |
| 04/24/2003 | CA2463020A1 Use of gp130 activators in diabetic neuropathy |
| 04/23/2003 | EP1304380A1 Human source gene leading sequence, gene vector and gene expression strategy |
| 04/23/2003 | EP1304378A1 ARL-2 for fertility control |
| 04/23/2003 | EP1304123A2 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 04/23/2003 | EP1304113A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1304112A1 Isolated stromal cells and methods of using the same |
| 04/23/2003 | EP1303625A2 Alpha-msh related compounds and methods of use |
| 04/23/2003 | EP1303620A2 Regulation of human desc1-like serine protease |
| 04/23/2003 | EP1303608A2 Zinc finger domain recognition code and uses thereof |
| 04/23/2003 | EP1303600A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/23/2003 | EP1303596A2 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 04/23/2003 | EP1303591A2 Masp-2, a complement-fixing enzyme, and uses for it |
| 04/23/2003 | EP1303588A2 Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue |
| 04/23/2003 | EP1303536A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 04/23/2003 | EP1303310A1 USE OF THE INTERFERON RECEPTOR 2c POLYPEPTIDE CHAIN TO ENHANCE THE ANTI-GROWTH EFFECTS OF TYPE I INTERFERONS |
| 04/23/2003 | EP1303303A1 Immunomodulatory human mhc class ii antigen-binding polypeptides |
| 04/23/2003 | EP1303302A2 Use of strains of the parapox ovis virus against organ fibrosis |
| 04/23/2003 | EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/23/2003 | EP1303183A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |